Target intelligence / Profile preview

Mitochondrial ribosomal protein L42 (MRPL42)

Target
MRPL42
Molecular classification
Ribosomal protein, Mitochondrial ribosomal protein, Structural protein
01

Overview

Mitochondrial ribosomal protein L42 (MRPL42) is a structural protein encoded by a nuclear gene, essential for the assembly and function of the mitochondrial ribosome (mitoribosome) in human cells. It participates in mitochondrial protein synthesis by forming part of both the small (28S) and large (39S) ribosomal subunits, although definitive subunit assignment remains under study. Unlike prokaryotic ribosomal proteins, mammalian mitoribosomal proteins, including MRPL42, have diverged significantly in sequence, complicating cross-species identification by homology. There are multiple transcript variants and pseudogenes of MRPL42 identified in the human genome. MRPL42's core function is as a structural constituent of the ribosome, facilitating mitochondrial translation that is essential for cellular energy metabolism. Mutation or dysfunction can disturb mitochondrial biogenesis, but MRPL42 itself has not been characterized as a direct therapeutic target and no drugs or specific inhibitors are currently known that act on MRPL42.

Other names
Large ribosomal subunit protein mL42MRPL31MRPS32RPML31HSPC204PTD007L31mtMRP-L31L42mtMRP-L42mL4239S ribosomal protein L31 (mitochondrial)39S ribosomal protein L42 (mitochondrial)28S ribosomal protein S32 (mitochondrial)MRP-S32S32MT
02

Biological functions

Mitochondrial protein synthesisStructural constituent of ribosomeRNA binding
03

Disease associations

Other (associated in databases with somatization disorder and glossopharyngeal neuralgia, but not established as a primary disease gene)
04

Safety considerations

Loss of function may impair mitochondrial translation and cellular energy production (general for mitochondrial ribosomal proteins)no specific clinical safety concerns reported

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L42 (MRPL42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L42 (MRPL42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call